Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19

Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients with cardiovascular multimorbidity (CVMM), enrolled in the prospective hospital registry.Material and methods. In patients with confirmed COVID...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Format:	Article
Language:	English
Published:	Столичная издательская компания 2022-11-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	new coronavirus infection prospective follow-up cardiovascular diseases cardiovascular multimorbidity long-term outcomes pharmacotherapy registry
Online Access:	https://www.rpcardio.online/jour/article/view/2816
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
by: N. P. Kutishenko, et al.
Published: (2023-01-01)

Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry
by: M. M. Lukyanov, et al.
Published: (2023-11-01)

Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry)
by: N. P. Kutishenko, et al.
Published: (2025-01-01)

Long-term outcomes in patients after COVID-19: data from the TARGET-VIP registry
by: M. M. Lukyanov, et al.
Published: (2022-04-01)

Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data)
by: S. Yu. Martsevich, et al.
Published: (2022-01-01)

Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry
by: M. M. Lukyanov, et al.
Published: (2022-01-01)

Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes
by: O. M. Drapkina, et al.
Published: (2020-12-01)

Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry)
by: E. Yu. Andreenkо, et al.
Published: (2020-05-01)

Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION)
by: E. Yu. Okshina, et al.
Published: (2019-11-01)

Early cardiovascular multimorbidity in out- and in-patient care: age characteristics and medication therapy (data from the REKVAZA and REKVAZA-CLINIC registries)
by: E. Yu. Andreenko, et al.
Published: (2020-11-01)

Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
by: Yu. V. Mareev, et al.
Published: (2023-01-01)

Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice
by: M. M. Loukianov, et al.
Published: (2020-03-01)

Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry)
by: N. P. Kutishenko, et al.
Published: (2022-09-01)

ORAL ANTICOAGULANTS IN AMBULATORY AND IN-HOSPITAL TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION ASSOCIATED WITH HYPERTENSION, ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE: DATA FROM HOSPITAL REGISTRY RECVASA-CLINIC
by: E. V. Stepina, et al.
Published: (2017-05-01)

Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data)
by: S. Yu. Martsevich, et al.
Published: (2022-03-01)

COMPARATIVE CHARACTERISTICS OF MULTIMORBIDITY, DRUG TREATMENT AND OUTCOMES IN POSTSTROKE PATIENTS WITH ATRIAL FIBRILLATION AND WITH OR WITHOUT HISTORY OF MYOCARDIAL INFARCTION (REGISTRY REGION DATA)
by: E. Yu. Okshina, et al.
Published: (2020-01-01)

SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
by: M. M. Loukianov, et al.
Published: (2016-03-01)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
by: M. M. Loukianov, et al.
Published: (2015-09-01)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015-09-01)

Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION
by: M. M. Loukianov, et al.
Published: (2019-01-01)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry
by: E. T. Guseinova, et al.
Published: (2022-11-01)

Cardiovascular risk management system: prerequisites for developing, organization principles, target groups
by: E. V. Shlyakhto, et al.
Published: (2019-11-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Standard transthoracic echocardiography. Guidelines 2024
by: S. T. Matskeplishvili, et al.
Published: (2025-03-01)

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register)
by: E. Yu. Andreenko, et al.
Published: (2019-12-01)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
by: M. M. Loukianov, et al.
Published: (2017-05-01)

Associations of neighborhood infrastructure with cardiovascular diseases and their risk factors: results of the ESSE-RF-3 epidemiological study
by: S. A. Maksimov, et al.
Published: (2025-02-01)

CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CONCOMITANT CARDIOVASCULAR PATHOLOGY, COMORBIDITIES AND TREATMENT IN THE REAL OUTPATIENT-POLYCLINIC PRACTICE
by: S. A. Boytsov, et al.
Published: (2014-12-01)

REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION"
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF
by: G. A. Muromtseva, et al.
Published: (2014-12-01)

Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now
by: S. A. Shalnova, et al.
Published: (2024-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
by: I. E. Chazova, et al.
Published: (2021-05-01)

THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS
by: S. A. Boytsov, et al.
Published: (2015-02-01)

Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years
by: A. V. Kontsevaya, et al.
Published: (2015-11-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Cardiovascular mortality rate in Moscow and St. Petersburg in 2015 and 2018
by: S. A. Boytsov, et al.
Published: (2021-02-01)

Prognostic value of socioeconomic parameters among the Russian population aged 25-64: results of a population-based study
by: A. E. Imaeva, et al.
Published: (2025-02-01)

Refusal of pharmacological treatment: prevalence and clinical importance
by: S. Yu. Martsevich, et al.
Published: (2025-06-01)